We have assessed the incidence of pain on injection of rocuronium and evaluated if pretreatment with lidocaine i.v. reduced it, in a randomized, controlled study in 90 patients. We found that 37% of patients who received lidocaine 10 mg pretreatment had pain on injection of rocuronium compared with 77% of patients who received saline pretreatment and 7% of patients who were pretreated with lidocaine 30 mg (PϽ0.05 in each instance compared with control). In addition, patients pretreated with lidocaine were less likely to suffer moderate or severe pain. Both lidocaine 10 mg and 30 mg i.v. given before administration of rocuronium significantly reduced the incidence and severity of pain on injection of rocuronium, and the higher dose was more effective. Rocuronium is given in precurarization, timing or priming without the use of local anaesthesia. All patients were monitored with an electrocardiograph, pulse oximeter and techniques before induction of anaesthesia. 1 2 (The timing an automatic non-invasive arterial pressure monitor. Patients principle entails administration of a single bolus dose of a were allocated randomly using sealed envelopes to receive non-depolarizing neuromuscular blocking agent followed isotonic saline (control group), lidocaine 10 mg or lidocaine by an induction drug at the onset of clinical weakness.) 30 mg at ambient temperature (20-24°C). All syringes were The incidence of pain on injection of rocuronium is high; prepared by another investigator and covered so that the reports suggest that 50-80% of patients suffer pain. 3 4 The investigator who assessed the patient's response was aim of this study was to examine the incidence of pain on unaware of the nature of the solution. Ten seconds after injection of rocuronium and to evaluate if prior administrainjection of the pretreatment drug, an intubating dose of tion of lidocaine 10 mg or 30 mg i.v. decreased the incidence rocuronium 0.6 mg kg -1 at room temperature was injected and severity of injection pain. over 10-15 s. The patient was asked during this period if his arm was comfortable and to report the severity of any
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Methods and results
pain on a four-point scale (none, mild, moderate, severe). After obtaining approval from the Institutional Ethics Com-Thirty seconds after administration of rocuronium, propofol mittee and informed consent, we studied 90 ASA I-II was administered i.v. until loss of consciousness and anaespatients undergoing a variety of orthopaedic and general thesia proceeded as planned. surgical procedures requiring general anaesthesia with positBased on an estimated incidence of approximately 80% ive pressure ventilation. Patients were allocated randomly of patients experiencing pain on injection of rocuronium, to one of three groups: lidocaine 10 mg, lidocaine 30 mg the sample size required to detect a 50% reduction at a or placebo (control). Those with difficult venous access or level of significance of 5% and a power of 90% was 30 requiring rapid sequence induction were excluded. Patients patients per group. Patient characteristics were compared were informed that they would be receiving a drug at the using the Student's t test. The chi-square test was used to start of their anaesthetic that may make their arm 'sting'. compare the incidence of pain in the three groups. Results They were told that they would be asked to score the were considered significant when PϽ0.05. pain, if any occurred, after the drug had been given. No There were no differences in patient characteristics premedication was given.
between the three groups in terms of mean age (control On arrival in the operating room, a 22-gauge cannula 34.9 (range 20-58) yr; lidocaine 10 mg 36.9 (18-62) yr; lidocaine 30 mg 37.7 (20-55) yr), sex distribution (control was placed in the largest vein on the dorsum of the hand Rocuronium injection pain and lidocaine pretreatment further to 7% when lidocaine 30 mg was given. The number of patients who complained of moderate and severe pain 20 males/10 females; lidocaine 10 mg 22 males/eight in the lidocaine 30 mg group was significantly smaller than females; lidocaine 30 mg 17 males/13 females) or mean that in the control group. A smaller incidence of moderate body weight (control 66.8 (SD 12.5) kg; lidocaine 10 mg and severe pain in the lidocaine 10 mg group compared 63.2 (15.2) kg; lidocaine 30 mg 64.8 (10.5) kg). Twenty-with the control group was also seen, although this was not three of 30 patients in the control group had pain on statistically significant. A dose-dependent effect of lidocaine injection of rocuronium (76.7%). Both lidocaine groups had in attenuating pain was present. While our study examined significantly lower incidences of pain compared with the only two doses of lidocaine pretreatment, perhaps a higher control group. Eleven of 30 patients (37%) in the lidocaine dose (such as 50 mg) may completely abolish rocuronium 10 mg group had pain on injection of rocuronium, which injection pain. was significantly greater than the two of 30 patients (7%)
Pain on injection of rocuronium is significant and perhaps in the lidocaine 30 mg group (PϽ0.05) ( Table 1 ). In other clinical strategies could be developed to prevent it. addition, patients who were pretreated with lidocaine 30 mg Rocuronium is an invaluable addition to our practice, before administration of rocuronium were less likely to allowing more rapid tracheal intubation. Attenuation of the suffer moderate or severe pain than those in the control pain caused by its injection could make it less distressing group (PϽ0.05).
for the patient to receive, and improve the quality of induction and acceptability of this otherwise useful agent.
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Pain associated with injection of rocuronium is common is probably caused by the low pH.
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